This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Agios Pharmaceuticals, Inc.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Gavin Whissell: Innovator in Aminolevulinic Acid Synthase Modulation
Introduction
Gavin Whissell is a notable inventor based in Belmont, MA (US). He has made significant contributions to the field of biotechnology, particularly in the treatment of various conditions through innovative methods.
Latest Patents
Gavin holds a patent titled "Methods of Treatment with Aminolevulinic Acid Synthase 2 (ALAS2) Modulators." This patent reflects his dedication to advancing medical treatments and improving patient outcomes.
Career Highlights
Gavin is currently employed at Agios Pharmaceuticals, Inc., where he continues to work on groundbreaking research and development projects. His expertise in the field has positioned him as a valuable asset to the company.
Collaborations
Gavin collaborates with talented colleagues, including Barden Chan and Shengfang Jin. Together, they contribute to the innovative environment at Agios Pharmaceuticals, Inc.
Conclusion
Gavin Whissell's work in the modulation of ALAS2 represents a significant advancement in medical treatment methodologies. His contributions to the field highlight the importance of innovation in biotechnology.